ArticleInternational journal of clinical and experimental pathology2018
Growth hormone-secreting adenoma coexisted with gangliocytoma: a rare case.
Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.Frontiers in endocrinology · 2022Article
- Combination tumors of the nervous system: A single-center analysis of a rare condition and comprehensive review of the literature.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A gangliocytoma in the sellar region is extremely rare. We report a rare case of mixed gangliocytoma and growth hormone (GH)-secreting adenoma in a 50-year-old woman, who presented with acromegaly. Laboratory investigations revealed high levels of GH and insulinlike growth factor 1 (IGF-1). Sellar computed tomography scan and contrast enhanced magnetic resonance imaging (CE-MRI) showed a sellar mass. Based on clinical, biochemical, and radiologic evaluations, GH-secreting adenoma was diagnosed and operated by endonasal transsphenoidal approach achieving total removal of the tumor. After surgery, histopathological examination demonstrated mixed gangliocytoma and GH-secreting adenoma in the resected lesion. The clinical, radiological, and operative data are reviewed, as are the histological findings. To our knowledge, few cases of mixed gangliocytoma and GH-secreting adenoma have been reported.
Indexed as
Identifiers
31949764PMC6962879W3026094573What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.